# Preservative-free Tafluprost/Timolol Fixed Combination: Morning vs Evening Dosing

> **NCT03612817** · PHASE4 · COMPLETED · sponsor: **Aristotle University Of Thessaloniki** · enrollment: 42 (actual)

## Conditions studied

- Glaucoma, Open-Angle

## Interventions

- **DRUG:** Tafluprost/timolol fixed combination

## Key facts

- **NCT ID:** NCT03612817
- **Lead sponsor:** Aristotle University Of Thessaloniki
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2018-04
- **Final completion:** 2018-07
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2020-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03612817

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03612817, "Preservative-free Tafluprost/Timolol Fixed Combination: Morning vs Evening Dosing". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03612817. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*